Home About CDC Press Room Funding A-Z Index Centers, Institute & Offices Training & Employment Contact Us
CDC Centers for Disease Control and Prevention Home Page
Health & Safety TopicsPublications & ProductsData & StatisticsConferences & Events
Program Contents
bullet Programs
Contact Info

English and Spanish
(800) CDC-INFO
(800) 232-4636
TTY: (888) 232-6348
FAX: (770) 488-4760

International Travel
Phone: 1-887-394-8747
email: cdcinfo@cdc.gov


Typhoid Fever

Clinical Features Typhoid fever has an insidious onset characterized by fever, headache, constipation, malaise, chills, and myalgia with few clinical features that reliably distinguish it from a variety of other infectious diseases. Diarrhea is uncommon, and vomiting is not usually severe. Confusion, delirium, intestinal perforation, and death may occur in severe cases. The etiologic agent may be recovered from the bloodstream or bone marrow, and occasionally from the stool or urine.
Etiologic Agent Salmonella serogroup Typhi.
Incidence 400 cases per year in the United States, mostly among travelers. An estimated 21 million cases of typhoid fever and 200,000 deaths occur worldwide.
Sequelae Without therapy, the illness may last for 3 to 4 weeks and death rates range between 12% and 30%.
Transmission Contaminated drinking water or food. Large epidemics are most often related to fecal contamination of water supplies or street vended foods. A chronic carrier state--excretion of the organism for more than 1 year--occurs in approximately 5% of infected persons.
Risk Groups Risk is very low in U.S.; higher among international travelers, and highest among persons living in poverty in the developing world.
Surveillance All reported cases are laboratory-confirmed in states or at CDC.
Trends Modest decrease in cases since 1994, possibly related to newly licensed vaccines marketed to international travelers.
Challenges Increasing resistance to available antimicrobial agents, including fluoroquinolones, may foretell dramatic increases in case-fatality rates. Epidemics and high endemic disease rates have occurred in the Central Asian Republics, the Indian subcontinent, and across Asia and the Pacific Islands. Growing evidence of previously unrecognized disease in children aged <5 years.
Opportunities The role of new and effective vaccines as control measures for epidemics and as tools for elimination remains to be explored.
Date: October 24, 2005
Content source: National Center for Immunization and Respiratory Diseases: Division of Bacterial Diseases
    Home   |   Policies and Regulations   |   Disclaimer   |   e-Government   |  FOIA   |  Contact Us  
Safer, Healthier People USA.govDHHS Department of Health
and Human Services
Centers for Disease Control and Prevention,1600 Clifton Rd, Atlanta, GA 30333, U.S.A
English and Spanish: (800) CDC-INFO / (800) 232-4636
TTY: (888) 232-6348 / FAX: (770) 488-4760